What is Polymedco CDP?
Polymedco CDP is a recognized leader in providing comprehensive healthcare services to medical professionals. The company specializes in non-invasive fecal immunochemical testing technology and bladder cancer monitoring, offering advanced diagnostic solutions that enhance patient care and early detection capabilities. Its commitment to innovation positions it at the forefront of medical diagnostics.
How much funding has Polymedco CDP raised?
Polymedco CDP has raised a total of $2.6M across 2 funding rounds:
Debt
$1M
Debt
$1.6M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.6M led by PPP
Key Investors in Polymedco CDP
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Polymedco CDP?
The recent enterprise-level funding for Polymedco CDP signals a strategic phase of expansion and technological advancement. This capital injection is expected to fuel further research and development in its core areas of non-invasive testing, potentially leading to new product lines or enhancements to existing diagnostic platforms. The company is poised to solidify its leadership in fecal immunochemical testing and bladder cancer monitoring, leveraging this investment to broaden its market reach and impact on global healthcare.
See full Polymedco CDP company page
